125 related articles for article (PubMed ID: 22658364)
21. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling.
Donato LJ; Noy N
Cancer Res; 2005 Sep; 65(18):8193-9. PubMed ID: 16166294
[TBL] [Abstract][Full Text] [Related]
22. Simple and efficient knockdown of His-tagged proteins by ternary molecules consisting of a His-tag ligand, a ubiquitin ligase ligand, and a cell-penetrating peptide.
Hattori T; Okitsu K; Yamazaki N; Ohoka N; Shibata N; Misawa T; Kurihara M; Demizu Y; Naito M
Bioorg Med Chem Lett; 2017 Sep; 27(18):4478-4481. PubMed ID: 28807436
[TBL] [Abstract][Full Text] [Related]
23. A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II.
Sessler RJ; Noy N
Mol Cell; 2005 Apr; 18(3):343-53. PubMed ID: 15866176
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr Virus latent membrane protein 1 overcomes all-trans retinoic acid-induced apoptosis by inhibiting retinoic acid receptor-β₂ expression.
Lee H; Seo SY; Tiwari I; Jang KL
Biochem Biophys Res Commun; 2012 Jun; 423(2):313-8. PubMed ID: 22659417
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of nuclear receptor-degradation inducers.
Itoh Y; Kitaguchi R; Ishikawa M; Naito M; Hashimoto Y
Bioorg Med Chem; 2011 Nov; 19(22):6768-78. PubMed ID: 22014751
[TBL] [Abstract][Full Text] [Related]
26. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
Tian K; Norris AW; Lin CL; Li E
Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
[TBL] [Abstract][Full Text] [Related]
27. Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy.
Ohoka N; Shibata N; Hattori T; Naito M
Curr Cancer Drug Targets; 2016; 16(2):136-46. PubMed ID: 26560118
[TBL] [Abstract][Full Text] [Related]
28. Effect of cellular senescence and retinoic acid on the expression of cellular retinoic acid binding proteins in skin fibroblasts.
Si SP; Tsou HC; Lee X; Peacocke M
Exp Cell Res; 1995 Jul; 219(1):243-8. PubMed ID: 7628539
[TBL] [Abstract][Full Text] [Related]
29. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
30. Mutual regulation of hypoxic and retinoic acid related signalling in tubular proximal cells.
Fernández-Martínez AB; Jiménez MI; Hernández IS; García-Bermejo ML; Manzano VM; Fraile EA; de Lucio-Cazaña FJ
Int J Biochem Cell Biol; 2011 Aug; 43(8):1198-207. PubMed ID: 21554977
[TBL] [Abstract][Full Text] [Related]
31. Expression of cellular retinoic acid-binding protein I and II (CRABP I and II) in embryonic mouse hearts treated with retinoic acid.
Stachurska E; Loboda A; Niderla-Bielińska J; Szperl M; Juszyński M; Jozkowicz A; Dulak J; Ratajska A
Acta Biochim Pol; 2011; 58(1):19-29. PubMed ID: 21409183
[TBL] [Abstract][Full Text] [Related]
32. Cellular retinoic acid-binding protein(II) presence in rat uterine epithelial cells correlates with their synthesis of retinoic acid.
Bucco RA; Zheng WL; Davis JT; Sierra-Rivera E; Osteen KG; Chaudhary AK; Ong DE
Biochemistry; 1997 Apr; 36(13):4009-14. PubMed ID: 9092831
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
34. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
35. Degradation of HaloTag-fused nuclear proteins using bestatin-HaloTag ligand hybrid molecules.
Tomoshige S; Naito M; Hashimoto Y; Ishikawa M
Org Biomol Chem; 2015 Oct; 13(38):9746-50. PubMed ID: 26338696
[TBL] [Abstract][Full Text] [Related]
36. Development of Small Molecule Chimeras That Recruit AhR E3 Ligase to Target Proteins.
Ohoka N; Tsuji G; Shoda T; Fujisato T; Kurihara M; Demizu Y; Naito M
ACS Chem Biol; 2019 Dec; 14(12):2822-2832. PubMed ID: 31580635
[TBL] [Abstract][Full Text] [Related]
37. Efficient protein knockdown of HaloTag-fused proteins using hybrid molecules consisting of IAP antagonist and HaloTag ligand.
Tomoshige S; Hashimoto Y; Ishikawa M
Bioorg Med Chem; 2016 Jul; 24(14):3144-8. PubMed ID: 27236416
[TBL] [Abstract][Full Text] [Related]
38. Small molecules destabilize cIAP1 by activating auto-ubiquitylation.
Sekine K; Takubo K; Kikuchi R; Nishimoto M; Kitagawa M; Abe F; Nishikawa K; Tsuruo T; Naito M
J Biol Chem; 2008 Apr; 283(14):8961-8. PubMed ID: 18230607
[TBL] [Abstract][Full Text] [Related]
39. Development of a Small Hybrid Molecule That Mediates Degradation of His-Tag Fused Proteins.
Okitsu K; Hattori T; Misawa T; Shoda T; Kurihara M; Naito M; Demizu Y
J Med Chem; 2018 Jan; 61(2):576-582. PubMed ID: 28460164
[TBL] [Abstract][Full Text] [Related]
40. Development of a peptide-based inducer of protein degradation targeting NOTCH1.
Ohoka N; Misawa T; Kurihara M; Demizu Y; Naito M
Bioorg Med Chem Lett; 2017 Nov; 27(22):4985-4988. PubMed ID: 29050782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
